{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1410001204273369986.json","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000000438996"}],"foaf:Person":[{"foaf:name":[{"@language":"ja","@value":"森 敏男"},{"@language":"en","@value":"MORI Toshio"}]}],"career":[{"institution":{"notation":[{"@language":"ja","@value":"グレラン製薬(株)開発研究センター"},{"@language":"en","@value":"Research Center, Grelan Pharmaceutical Co.,Ltd."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1390001204273369984","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1254/fpj.106.51"},{"@type":"COI","@value":"1:CAS:528:DyaK2MXmslGhsbY%3D"},{"@type":"PMID","@value":"7590523"},{"@type":"NDL_BIB_ID","@value":"3633233"},{"@type":"NDL_CALL_NUMBER","@value":"Z19-247"},{"@type":"URI","@value":"http://id.ndl.go.jp/bib/3633233"},{"@type":"URI","@value":"https://ndlsearch.ndl.go.jp/books/R000000004-I3633233"},{"@type":"NAID","@value":"10006060763"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/1996001770"}],"notation":[{"@language":"en","@value":"Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. II. Anti-atheromatous effects are independent of its hypolipidemic effect in hereditary hyperlipidemic rabbits."},{"@value":"抗高脂血症薬フェノフィブラートの抗動脈硬化作用　（ＩＩ）　遺伝的高脂血症ウサギにおける血清脂質低下作用を介さない抗動脈硬化作用"},{"@language":"ja-Kana","@value":"コウ コウ シケツショウヤク フェノフィブラート ノ コウ ドウミャク コウカ"}],"relation":[{"type":"creator"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679250081024","@type":"Article","resourceType":"学術雑誌論文(journal article)","productIdentifier":[{"@type":"DOI","@value":"10.1254/fpj.106.41"},{"@type":"COI","@value":"1:CAS:528:DyaK2MXmslGhsbk%3D"},{"@type":"PMID","@value":"7590522"},{"@type":"NDL_BIB_ID","@value":"3633232"},{"@type":"NDL_CALL_NUMBER","@value":"Z19-247"},{"@type":"URI","@value":"http://id.ndl.go.jp/bib/3633232"},{"@type":"URI","@value":"https://ndlsearch.ndl.go.jp/books/R000000004-I3633232"},{"@type":"NAID","@value":"10006060721"},{"@type":"NAID","@value":"30034987315"},{"@type":"URI","@value":"https://search.jamas.or.jp/link/ui/1996001769"}],"notation":[{"@language":"en","@value":"Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. I. Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits."},{"@value":"抗高脂血症薬フェノフィブラートの抗動脈硬化作用　（Ｉ）　コレステロール負荷ウサギにおける血清脂質低下作用を介さない抗動脈硬化作用"},{"@language":"ja-Kana","@value":"コウ コウ シケツショウヤク フェノフィブラート ノ コウ ドウミャク コウカ"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"JALC","@value":"oai:japanlinkcenter.org:0008167016_T5FddoDC1nUr4GwColr6TtEZ4SO"},{"@type":"JALC","@value":"oai:japanlinkcenter.org:0008167015_T5FddoDC1nUr4GwColr6TtEZ4SO"},{"@type":"CIA","@value":"10006060721_JpxUTV27bauCS05y4ahqw3FPMXA"},{"@type":"CIA","@value":"10006060763_JpxUTV27bauCS05y4ahqw3FPMXA"},{"@type":"CROSSREF","@value":"10.1254/fpj.106.41_DFpXyRJflR0PVNHLupvLk4JLOcz"},{"@type":"CROSSREF","@value":"10.1254/fpj.106.51_DFpXyRJflR0PVNHLupvLk4JLOcz"}]}